November 19, 2026 · BMC women's health · DOI: 10.1186/s12905-026-04817-0

Retrospective analysis of HER2 expression status as a prognostic factor in PTK6-positive triple-negative breast cancer.

Listen to this summary

This retrospective study of 94 PTK6-positive triple-negative breast cancer patients asked whether HER2-low expression affects prognosis and how it relates to PTK6 status. Sixty-five percent of patients were HER2-low, a status associated with older age, but HER2-low versus HER2-zero status did not significantly change disease-free or overall survival. Age and nodal stage emerged as independent prognostic factors, highlighting heterogeneity within PTK6-positive TNBC.

Yuexia Chen, Qiaoli Ke, Wei Qu, Jianhong Tu, Liu Yang

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play